Gilead: Here's What to Expect From Gilead Sciences' Next Earnings Report
Gilead Sciences is expected to announce its fiscal first-quarter earnings this month, and analysts forecast a robust triple-digit in its earnings.
Read full article »
Gilead is a California-based biopharmaceutical company that develops and commercializes antiviral drugs for a wide range of diseases.
Read more